Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet

AUTOR(ES)

van der Horst, Iwan CC

FONTE

BioMed Central

RESUMO

There is no hard evidence yet for a positive effect of glucose–insulin–potassium infusion in sepsis, septic shock or burn patients. Each individual element of the glucose–insulin–potassium regimen, and eventually euglycaemia, should theoretically be beneficial. At present, evidence exists only for reduced mortality with strict metabolic treatment (i.e. blood glucose levels of 4.4–6.1 mmol/l) in critically ill patients admitted to surgical intensive care units, and for better metabolic regulation (i.e. blood glucose levels of 7.0–10.0 mmol/l) in patients with hyperglycaemia and/or diabetes mellitus, and in patients without signs of heart failure (i.e. Killip class I) during acute myocardial infarction.

Documentos Relacionados

• Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction.
• Sustained effect of glucose-insulin-potassium on myocardial performance during regional ischemia. Role of free fatty acid and osmolality.
• Cortisol replacement for severe sepsis and septic shock: what should I do?
• Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
• Steroids in septic shock: the confusion continues